Trial intelligence / Profile preview

Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

NCT03251287Phase 1Unknown

Sponsor
University of East Anglia
Start
Nov 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Sodium Nitrate with Placebo (2 arms). Primary endpoint: Cardiac Energetic Status. Status: unknown.

02

Drugs

sodium nitrate
03

Conditions

hypertrophic cardiomyopathy (HCM)

Beyond the preview

Go deeper on NCT03251287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03251287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call